Theryte of Liverpool (WO 99/42835) describes a test to determine which
chemotherapy agent is best for treating a particular tumour: chemotherapy with
cis-platinum or taxanes such as taxol. Theryte’s trick is to fluorescently label
a tumour biopsy sample with antibodies against the telltale cyclin D1 protein.
If laser light highlights an abundance of D1, taxane treatment is recommended;
if D1 is absent, cis-platinum is prescribed. This, says Theryte, saves
money—and lives—by quickly finding the most appropriate treatment.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Technology
OpenAI’s hacking agent went rogue. Should we be worried?
News
Technology
China is trying to regulate relationships with AI – can it work?
News
Technology
The ancient Silk Road city that has a lesson for Silicon Valley
Comment
Technology
Why a Ukrainian cruise missile is flying with hobby drone hardware
News
Popular articles
Trending Â鶹´«Ã½ articles